NEVRO CORP.
Manufacturer adverse-event records for NEVRO CORP. come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.
FDA MAUDE device safety record · 2017–2026 · thin-book · elevated Death-code · injury-heavy
Death-code intensity
NEVRO CORP. carries an elevated Death-code share
Death-coded event_type rows are 931 of 5,983 (15.56% · elevated tercile among 434 manufacturers). Absolute volume is thin-book.
What the Death-code reading shows for NEVRO CORP.
The standout signal for NEVRO CORP. is Death-code intensity: 15.56% of 5,983 reports (elevated tercile), while absolute volume is thin-book.
As a thinner-book manufacturer, a handful of device families can swing the totals; open the device table rather than reading the company headline alone. Event_type counts are not the same population as Patient Outcomes.
Reports span 2 device types, led in this extract by Injury at 4,814 (80.5% of event_type total). Peak single-year volume reaches 1,173 reports across 10 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Devices (2)
| Device | Reports |
|---|---|
| Stimulator, Spinal-Cord, Totally Implanted For Pain Relief | 5,981 |
| Sacroiliac Joint Fixation | 2 |
Yearly Trend
Read our methodology - how this data is sourced, computed, and verified.